Zinzino AB (publ.) has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company’s distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Sanki’s subsidiaries in Colombia and Peru are being acquired to accelerate the establishment processes and increase distribution power in those countries.
The acquisition of Sanki adds increased distribution power in combination with an innovative, trademarked product portfolio, tailored to be integrated into Zinzino‘s test-based product concept.
The asset acquisition is also another strategically important step in Zinzino‘s growth plans, with a focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.
Sanki is a direct sales company in the health segment, operating in North America (USA and Mexico) and South America (Colombia and Peru). Its brand portfolio offers a range of innovative and patented products in the field of health and well-being. The business has a total annual turnover of approximately USD 12 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with the integration of Sanki’s product portfolio into
Tag Archive for Biotechnology
Hot Business News Today
Zinzino Completes Acquisition of Truvy, Increasing North America, Latin America, South Korea Distribution
by Press Release • • 0 Comments
Zinzino (Zinzino AB) announced its letter of intent earlier this month to acquire the North American direct sales company Truvy. Zinzino has now completed the acquisition process and thereby acquired the rights to Truvy’s distributor database and associated customer register, inventory, and IP rights. In addition to the assets, 100% of the shares in Truvy’s South Korean subsidiary have been acquired to accelerate the establishment process and increase distribution power in the country.
This is another strategically important step in Zinzino’s growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.
Truvy is a global direct sales company in the health segment, operating in North America, Latin America, and South Korea. Its brand portfolio offers a range of innovative products in the areas of health and weight loss.
The business has a total annual turnover of approximately USD 12 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with Zinzino’s test-based product concept. Profitability through the transactions will thus be able to develop well by utilizing Zinzino’s existing technical platform and organization.
Upon completion, Zinzino will pay a fixed purchase
Hot Business News Today
Zinzino Acquires Bodē Pro, Increasing Distribution Power in North America and Japan
by Press Release • • 0 Comments
Zinzino (Zinzino AB) has today acquired the rights to the distributor database and associated customer register, inventory, and IP rights of US-based direct sales company Bodē Pro through an asset acquisition. This is another strategically important step in Zinzino‘s growth plans, which focus on improving personal health and well-being on a global level with innovative biotechnology and a groundbreaking product portfolio marketed through direct sales.
Bodē Pro is a global direct sales company in the health segment, operating primarily in North America and Japan. Its brand portfolio offers a range of innovative products in the health and wellness sector.
The business has a total annual turnover of approximately USD 7 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with Zinzino’s test-based product concept and Bodē Pro’s innovative product range. Profitability through the transactions will thus be able to develop well by utilizing Zinzino’s existing technical platform and organization.
The partnership will also accelerate Zinzino’s expansion in Japan, one of the most sought-after markets in the direct sales industry. Approximately 55% of Bodē Pro’s total revenue currently comes from the Japanese market.
According to the asset purchase agreement, Zinzino will pay a fixed purchase price of USD 2 million upon
Hot Business News Today
THREE International Welcomes Three New Scientific Advisory Board Members
by Press Release • • 0 Comments
World-renowned experts in medicine, wellness, and biotechnology join proactive wellness company’s advisory board
THREE International announced Tuesday the addition of three distinguished leaders in science and medicine to its Scientific Advisory Board (SAB): Dr. Roy Rong, Dr. Deirdre Leake, and Professor Sastia Putri. Their combined expertise across clinical medicine, biotechnology, regenerative science, and proactive wellness marks a significant expansion of THREE’s commitment to delivering cutting-edge, science-backed health options.
“At THREE, we leverage science to redefine what’s possible,”
said Dr. Dan Gubler, Chief Scientific Officer at THREE.
“We are honored to welcome these visionary experts to our Scientific Advisory Board as we continue to pioneer new frontiers in proactive wellness and cellular absorption technology.”
Dr. Roy Rong, a physician-scientist and healthcare executive, brings decades of global experience from across the U.S., Europe, and Asia. With a doctorate in medicine from Kiel University and postdoctoral research at Harvard Medical School, Dr. Rong has led breakthrough work in urologic oncology and psychosomatic medicine. He currently serves as General Manager for AtriCure China and is the Founder and Chief Medical Officer of the International Health and Medical Association.
Dr. Deirdre Leake is a double board-certified facial plastic surgeon with nearly two decades of experience in private practice. A recognized
Hot Business News Today
The CEO of This Biotech Company Focused on Rare Diseases Is a Patient Himself
by BizCast • • 0 Comments
Hot Business News Today
Alphabet and GlaxoSmithKline to Collaborate on Bioelectronic Research
by Tom Brant • • 0 Comments
Hot Business News Today
The Obsession With 'Curing' Aging Is Now Big Business
by Laura Lorenzetti • • 0 Comments
Finding ways to extend a healthy life has attracted many tens of millions in investment dollars from the likes of Google and numerous biotechnology companies.
Hot Business News Today
2 Biotech Companies Lead the Race to Develop a Zika Vaccine
by Carolyn Sun • • 0 Comments
Hot Business News Today
Great Achievements: Tim Cook Gets Honored and an Important Drug Snags FDA Approval
by Nina Zipkin • • 0 Comments
Hot Business News Today
Biotechnology Expert Dr. Jesús Bustillos Joins Ariix Wellness Council
by Ramya Chandrasekaran • • 0 Comments
ARIIX, an international opportunity company that promotes healthy, toxic-free living, is excited to announce the appointment of Jesús Bustillos, Ph.D., to the ARIIX Wellness Council. An internationally recognized diabetes educator, physician, and surgeon, Dr. Bustillos holds a Master of Science with specialization in medical emergencies and a Ph.D. in biotechnology.
The ARIIX Wellness Council is made up of an exclusive group of experts and professionals that help shape the decisions and direction of the global ARIIX branded lines. As a member of the Council, Dr. Bustillos will join with his peers in raising awareness of the branded products within ARIIX and creating opportunities for improved health and wellness within his community and around the world.
“I have the firm intention to collaborate with ARIIX to increase human consciousness in biological, mental, and social health,”